Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

BMC Cancer20099:145

DOI: 10.1186/1471-2407-9-145

Received: 28 January 2009

Accepted: 13 May 2009

Published: 13 May 2009

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
28 Jan 2009 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Mar 2009 Reviewed Reviewer Report - Pierre Laurent-Puig
12 Mar 2009 Reviewed Reviewer Report - Igor Jurisica
2 Apr 2009 Author responded Author comments - Esther Black
Resubmission - Version 3
2 Apr 2009 Submitted Manuscript version 3
26 Apr 2009 Reviewed Reviewer Report - Pierre Laurent-Puig
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
13 May 2009 Editorially accepted
13 May 2009 Article published 10.1186/1471-2407-9-145

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky

Advertisement